CA2012867A1 - Depsipeptides cycliques cytotoxiques nouveaux isoles du tunicier trididemnum solidum - Google Patents

Depsipeptides cycliques cytotoxiques nouveaux isoles du tunicier trididemnum solidum

Info

Publication number: CA2012867A1
Authority: CA; Canada
Prior art keywords: cyclic depsipeptides; novel cytotoxic; trididemnum solidum; cytotoxic cyclic; tunicate
Prior art date: 1989-04-10
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.): Granted

Application number

CA2012867A

Other languages

English (en)

Other versions

CA2012867C (fr

Inventor

Kenneth L. Rinehart, Jr.

Ryuichi Sakai

Justin G. Stroh

Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)

University of Illinois System

Original Assignee

University of Illinois System

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1989-04-10

Filing date

1990-03-22

Publication date

1990-10-10

1990-03-22 Application filed by University of Illinois System filed Critical University of Illinois System

1990-10-10 Publication of CA2012867A1 publication Critical patent/CA2012867A1/fr

1999-09-21 Application granted granted Critical

1999-09-21 Publication of CA2012867C publication Critical patent/CA2012867C/fr

2010-03-22 Anticipated expiration legal-status Critical

Status Expired - Fee Related legal-status Critical Current

Links

241000804473 Trididemnum solidum Species 0.000 title abstract 2
230000001472 cytotoxic effect Effects 0.000 title abstract 2
108010002156 Depsipeptides Proteins 0.000 title 1
231100000433 cytotoxic Toxicity 0.000 title 1
KYHUYMLIVQFXRI-XYUQHQMCSA-N (2s)-n-[(2r)-1-[[(3s,6s,8s,12s,13r,16s,17r,20s,23s)-13-[(2s)-butan-2-yl]-12-hydroxy-20-[(4-methoxyphenyl)methyl]-6,17,21-trimethyl-3-(2-methylpropyl)-2,5,7,10,15,19,22-heptaoxo-8-propan-2-yl-9,18-dioxa-1,4,14,21-tetrazabicyclo[21.3.0]hexacosan-16-yl]amino Chemical class CN([C@H](CC(C)C)C(=O)N[C@@H]1C(=O)N[C@@H]([C@H](CC(=O)O[C@H](C(=O)[C@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N2CCC[C@H]2C(=O)N(C)[C@@H](CC=2C=CC(OC)=CC=2)C(=O)O[C@@H]1C)C(C)C)O)[C@@H](C)CC)C(=O)[C@@H]1CCCN1C(=O)C(C)O KYHUYMLIVQFXRI-XYUQHQMCSA-N 0.000 abstract 1
GXKAOWYTJPGGBI-BHTIDRDUSA-N (4s)-4-[[(2s)-5-amino-2-[[(2s)-5-amino-2-[[(2s)-5-amino-2-[[(3r)-3-hydroxydecanoyl]amino]-5-oxopentanoyl]amino]-5-oxopentanoyl]amino]-5-oxopentanoyl]amino]-5-[(2s)-1-[(2s)-2-[[(2r)-1-[[(3s,6s,8s,12s,13s,16s,17s,20s,23s)-13-[(2s)-butan-2-yl]-12-hydroxy-20- Chemical compound CCCCCCC[C@@H](O)CC(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCC(O)=O)C(=O)O[C@@H](C)C(=O)N1CCC[C@H]1C(=O)N(C)[C@H](CC(C)C)C(=O)N[C@@H]1C(=O)N[C@@H]([C@@H](C)CC)[C@@H](O)CC(=O)O[C@@H](C(C)C)C(=O)[C@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N2CCC[C@H]2C(=O)N(C)[C@@H](CC=2C=CC(OC)=CC=2)C(=O)O[C@H]1C GXKAOWYTJPGGBI-BHTIDRDUSA-N 0.000 abstract 1
BUHGEDVBBOQECR-HGESRAKOSA-N (4s)-4-[[(2s)-5-amino-2-[[(2s)-5-amino-2-[[(3r)-3-hydroxydecanoyl]amino]-5-oxopentanoyl]amino]-5-oxopentanoyl]amino]-5-[(2s)-1-[(2s)-2-[[(2r)-1-[[(3s,6s,8s,12s,13s,16s,17s,20s,23s)-13-[(2s)-butan-2-yl]-12-hydroxy-20-[(4-methoxyphenyl)methyl]-6,17,21-trime Chemical compound CCCCCCC[C@@H](O)CC(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCC(O)=O)C(=O)O[C@@H](C)C(=O)N1CCC[C@H]1C(=O)N(C)[C@H](CC(C)C)C(=O)N[C@@H]1C(=O)N[C@@H]([C@@H](C)CC)[C@@H](O)CC(=O)O[C@@H](C(C)C)C(=O)[C@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N2CCC[C@H]2C(=O)N(C)[C@@H](CC=2C=CC(OC)=CC=2)C(=O)O[C@H]1C BUHGEDVBBOQECR-HGESRAKOSA-N 0.000 abstract 1
239000002246 antineoplastic agent Substances 0.000 abstract 1
229940041181 antineoplastic drug Drugs 0.000 abstract 1
150000001875 compounds Chemical class 0.000 abstract 1

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K11/00—Depsipeptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
- C07K11/02—Depsipeptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof cyclic, e.g. valinomycins ; Derivatives thereof
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
- C07K7/02—Linear peptides containing at least one abnormal peptide link
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides

Landscapes

Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
General Health & Medical Sciences (AREA)
Medicinal Chemistry (AREA)
Biochemistry (AREA)
Biophysics (AREA)
Genetics & Genomics (AREA)
Molecular Biology (AREA)
Proteomics, Peptides & Aminoacids (AREA)
Chemical Kinetics & Catalysis (AREA)
Veterinary Medicine (AREA)
Public Health (AREA)
Animal Behavior & Ethology (AREA)
General Chemical & Material Sciences (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Pharmacology & Pharmacy (AREA)
Virology (AREA)
Oncology (AREA)
Communicable Diseases (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Peptides Or Proteins (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Preparation Of Compounds By Using Micro-Organisms (AREA)
Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Nitrogen Condensed Heterocyclic Rings (AREA)

CA002012867A 1989-04-10 1990-03-22 Depsipeptides cycliques cytotoxiques nouveaux isoles du tunicier trididemnum solidum Expired - Fee Related CA2012867C (fr)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
US07/335,903 US4948791A (en)	1989-04-10	1989-04-10	Novel Cytotoxic cyclic depsipeptides from the tunicate trididemnum solidum
US335,903		1989-04-10

Publications (2)

Publication Number	Publication Date
CA2012867A1 true CA2012867A1 (fr)	1990-10-10
CA2012867C CA2012867C (fr)	1999-09-21

Family

ID=23313708

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
CA002012867A Expired - Fee Related CA2012867C (fr)	1989-04-10	1990-03-22	Depsipeptides cycliques cytotoxiques nouveaux isoles du tunicier trididemnum solidum

Country Status (10)

Country	Link
US (1)	US4948791A (fr)
EP (1)	EP0393883B1 (fr)
JP (1)	JP3431920B2 (fr)
AT (1)	ATE183751T1 (fr)
AU (1)	AU640130B2 (fr)
CA (1)	CA2012867C (fr)
DE (1)	DE69033257T2 (fr)
DK (1)	DK0393883T3 (fr)
ES (1)	ES2140373T3 (fr)
GR (1)	GR3031846T3 (fr)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US20030148933A1 (en)	1990-10-01	2003-08-07	Pharma Mar S.A.	Derivatives of dehydrodidemnin B
DE4120327A1 (de) *	1991-06-20	1992-12-24	Basf Ag	Neue peptide, ihre herstellung und verwendung
US6156724A (en) *	1996-06-07	2000-12-05	Rinehart; Kenneth L.	Uses of didemnins as immunomodulating agents
US5830996A (en) *	1996-09-27	1998-11-03	University Of Utah Research Foundation	Cyclic peptide antitumor agent from an ascidian
ATE321773T1 (de)	1996-10-24	2006-04-15	Univ Illinois	Semisynthetisches verfahren zur herstellung von didemninanalogen
US6034058A (en) *	1997-04-15	2000-03-07	Rinehart; Kenneth L.	Semi-synthetic alanyl dilemnin analogs
GB9803448D0 (en)	1998-02-18	1998-04-15	Pharma Mar Sa	Pharmaceutical formulation
UA76718C2 (uk) *	2000-06-30	2006-09-15	Фарма Мар, С.А.	Протипухлинні похідні аплідину
GB0103750D0 (en) *	2001-02-15	2001-04-04	Pharma Mar Sa	Synthetic methods for aplidine and new antitumoral derivatives methods of making and using them
HK1054191A1 (zh)	2000-10-12	2003-11-21	Pharma Mar, S.A.	施用aplidine時同時使用myoprotector的癌症治療
WO2004080477A1 (fr)	2003-03-12	2004-09-23	Dana-Farber Cancer Institute, Inc.	Aplidine utilisee dans le traitement du myelome multiple
JP2006519848A (ja)	2003-03-12	2006-08-31	ファルマ・マール・ソシエダード・アノニマ	改良された抗腫瘍治療
KR20140101014A (ko)	2006-02-28	2014-08-18	파르마 마르 에스.에이.	개선된 항종양 치료
JOP20190254A1 (ar)	2017-04-27	2019-10-27	Pharma Mar Sa	مركبات مضادة للأورام

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
FR2576022B1 (fr) *	1985-01-11	1987-09-11	Rhone Poulenc Sante	Nouveaux derives de la pristinamycine ii b, leur preparation et les compositions pharmaceutiques qui les contiennent

1989
- 1989-04-10 US US07/335,903 patent/US4948791A/en not_active Expired - Lifetime
1990
- 1990-03-22 CA CA002012867A patent/CA2012867C/fr not_active Expired - Fee Related
- 1990-04-05 AT AT90303672T patent/ATE183751T1/de not_active IP Right Cessation
- 1990-04-05 DE DE69033257T patent/DE69033257T2/de not_active Expired - Fee Related
- 1990-04-05 EP EP90303672A patent/EP0393883B1/fr not_active Expired - Lifetime
- 1990-04-05 ES ES90303672T patent/ES2140373T3/es not_active Expired - Lifetime
- 1990-04-05 DK DK90303672T patent/DK0393883T3/da active
- 1990-04-09 AU AU53053/90A patent/AU640130B2/en not_active Ceased
- 1990-04-10 JP JP09327490A patent/JP3431920B2/ja not_active Expired - Fee Related
1999
- 1999-11-16 GR GR990402940T patent/GR3031846T3/el unknown

Also Published As

Publication number	Publication date
AU5305390A (en)	1990-10-11
ATE183751T1 (de)	1999-09-15
CA2012867C (fr)	1999-09-21
US4948791A (en)	1990-08-14
AU640130B2 (en)	1993-08-19
EP0393883B1 (fr)	1999-08-25
DK0393883T3 (da)	2000-03-20
GR3031846T3 (en)	2000-02-29
ES2140373T3 (es)	2000-03-01
DE69033257D1 (de)	1999-09-30
JPH03135999A (ja)	1991-06-10
JP3431920B2 (ja)	2003-07-28
DE69033257T2 (de)	2000-04-13
EP0393883A1 (fr)	1990-10-24

Similar Documents

Publication	Publication Date	Title
PH31059A (en)	1998-02-05	Pharmaceutical compositions comprising cyclosporins.
GB2195889B (en)	1990-08-01	Pharmaceutical antioxidant composition produced from plants.
CA2012867A1 (fr)	1990-10-10	Depsipeptides cycliques cytotoxiques nouveaux isoles du tunicier trididemnum solidum
CA2126091A1 (fr)	1993-08-05	Nouveaux polypeptides biologiquement actifs, leur preparation et composition pharmaceutique les contenant
CA2180816A1 (fr)	1997-01-12	6-dimethylaminomethyl-1-phenylcyclohexanes, principes actifs en pharmacie
CA2193337A1 (fr)	1997-06-21	Composes de type 1-phenyl-2-dimethylaminomethylcyclohexan-1-o1, ingredients pharmaceutiques actifs
GR3032366T3 (en)	2000-04-27	Pharmaceutical cyclosporin composition.
CA2100745A1 (fr)	1993-05-20	Peptides agonistes de l'amyline et leur utilisation
CA2154424A1 (fr)	1996-01-24	1-phenyl-3-dimethylaminopropane possedant des proprietes pharmaceutiques
IL88898A (en)	1993-07-08	1,2-bis (aminomethyl) -cyclobutane-platinum complexes, their preparation and pharmaceutical compositions containing them
NZ240838A (en)	1993-11-25	N,o-sulphated heparosans, preparation using e.coli and pharmaceutical compositions thereof
CA2150251A1 (fr)	1994-11-10	Lyospheres contenant de la gonadotropine
IE891224L (en)	1989-10-18	Macrolide compositions
CA2199679A1 (fr)	1997-09-13	Composes de dimethyl-(3-aryl-but-3-enyl)-amine comme ingredients actifs dans des produits pharmaceutiques
AU2705588A (en)	1989-06-22	New ciclosporin crystal form, processes for its production, pharmaceutical compositions containing it and its use.
EP0353678A3 (fr)	1991-03-20	Dérivés FR-901154 et FR-901155, procédé pour leur production
AU2710892A (en)	1993-04-29	Cytotoxic bicyclo (7.3.1) tridec-4-ene-2,6-diyne compounds and process for the preparation thereof
AU7035991A (en)	1991-07-18	Indolocarbazoles from saccharothrix aerocolonigenes subsp. copiosa subsp. nov. scc 1951 atcc 53856
CA2002483A1 (fr)	1990-05-14	Analogue de la fluoxetine
AU7547787A (en)	1988-01-12	Dibenz(b,e)oxepin derivative and pharmaceutical containing the same as active ingredient
EP0297594A3 (fr)	1990-07-25	Dérivés glucosidiques de l'épipodophyllotoxine substitués par des atomes d'azote en position 3' et 4'
IL90548A0 (en)	1990-01-18	Antitumor antibiotic designated bu-3420t,its preparation and pharmaceutical compositions containing it
CA2301273A1 (fr)	1999-03-11	Table avec sieges qui se deplacent en bloc sur son pourtour
GB2189490B (en)	1990-02-14	Physiologically-active tripeptide.
AU6403590A (en)	1991-04-18	Isolated, physiologically active human thrombomodulin polypeptide

Legal Events

Date	Code	Title	Description
1993-09-27	EEER	Examination request
2008-03-25	MKLA	Lapsed